• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人类体质类型对正常个体进行免疫表型分析。

Immunophenotyping of normal individuals classified on the basis of human dosha prakriti.

作者信息

Rotti Harish, Guruprasad Kanive Parashiva, Nayak Jayakrishna, Kabekkodu Shama Prasada, Kukreja Harpreet, Mallya Sandeep, Nayak Jyothi, Bhradwaj Ramachandra C, Gangadharan G G, Prasanna B V, Raval Ritu, Kamath Asha, Gopinath Puthiya Mundyat, Kondaiah Paturu, Satyamoorthy Kapaettu

机构信息

Division of Biotechnology, School of Life Sciences, Manipal University, Manipal, Karnataka, India.

Department of Shalyatantra/ Roganidana, Shri Dharmasthala Manjunatheshwara College of Ayurveda, Udupi, Karnataka, India.

出版信息

J Ayurveda Integr Med. 2014 Jan;5(1):43-9. doi: 10.4103/0975-9476.128857.

DOI:10.4103/0975-9476.128857
PMID:24812475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4012362/
Abstract

BACKGROUND

Human variations related to immune response and disease susceptibility is well-documented in Ayurveda. Prakriti (body constitution) is the basic constitution of an individual established at the time of birth and distinguishes variations, into three broad phenotype categories such as vata, pitta and kapha. Variation in immune response is often attributed to and measured from the difference in cluster differentiation (CD) markers expressed in lymphocytes. Currently, there are no reports available on the expression of CD markers related to prakriti.

OBJECTIVE

This is a pilot study performed to evaluate a panel of lymphocyte subset CD markers in dominant prakriti individuals.

MATERIALS AND METHODS

Immunophenotyping was carried out using whole blood from a total of healthy 222 subjects, who are grouped into kapha (n = 95), pitta (n = 57) and vata (n = 70) prakritis. CD markers such as CD3, CD4, CD8, CD14, CD25, CD56, CD69, CD71 and HLA-DR were analyzed using flow cytometry method. Differences between groups were analyzed using one-way ANOVA or Kruskal-Wallis analysis of variance (ANOVA) and multiple comparisons between groups were performed by Bonferroni or Mann-Whitney U test with corrections for type I error respectively. Significance was evaluated by ANOVA and Pearson's correlation.

RESULTS

We observed a significant difference (P < 0.05) in the expression of CD markers such as CD14 (monocytes), CD25 (activated B cells) and CD56 (Natural killer cells) between different prakriti groups. CD25 and CD56 expression was significantly higher in kapha prakriti samples than other prakriti groups. Similarly, slightly higher levels of CD14 were observed in pitta prakriti samples.

CONCLUSION

Significant difference in the expression of CD14, CD25 and CD56 markers between three different prakriti is demonstrated. The increased level of CD25 and CD56 in kapha prakriti may indicate ability to elicit better immune response, which is in conformity with textual references in Ayurveda.

摘要

背景

阿育吠陀医学中已有充分文献记载与免疫反应和疾病易感性相关的人类变异。体质是个体出生时确立的基本体质,可分为三种广泛的表型类别,即风型、火型和水型。免疫反应的差异通常归因于淋巴细胞中表达的分化群(CD)标志物的差异,并以此进行测量。目前,尚无关于与体质相关的CD标志物表达的报道。

目的

这是一项初步研究,旨在评估占主导地位的体质个体中的一组淋巴细胞亚群CD标志物。

材料与方法

使用来自总共222名健康受试者的全血进行免疫表型分析,这些受试者被分为水型(n = 95)、火型(n = 57)和风型(n = 70)体质。使用流式细胞术方法分析CD3、CD4、CD8、CD14、CD25、CD56、CD69、CD71和HLA - DR等CD标志物。组间差异采用单因素方差分析或Kruskal - Wallis方差分析进行分析,组间多重比较分别采用Bonferroni或Mann - Whitney U检验并对I型错误进行校正。通过方差分析和Pearson相关性评估显著性。

结果

我们观察到不同体质组之间CD标志物如CD14(单核细胞)、CD25(活化B细胞)和CD56(自然杀伤细胞)的表达存在显著差异(P < 0.05)。水型体质样本中CD25和CD56的表达显著高于其他体质组。同样,在火型体质样本中观察到CD14水平略高。

结论

证明了三种不同体质之间CD14、CD25和CD56标志物表达存在显著差异。水型体质中CD25和CD56水平的升高可能表明其引发更好免疫反应的能力,这与阿育吠陀医学的文献记载相符。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a89c/4012362/a84f5e4f0707/JAIM-5-43-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a89c/4012362/ff231d302004/JAIM-5-43-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a89c/4012362/a84f5e4f0707/JAIM-5-43-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a89c/4012362/ff231d302004/JAIM-5-43-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a89c/4012362/a84f5e4f0707/JAIM-5-43-g003.jpg

相似文献

1
Immunophenotyping of normal individuals classified on the basis of human dosha prakriti.基于人类体质类型对正常个体进行免疫表型分析。
J Ayurveda Integr Med. 2014 Jan;5(1):43-9. doi: 10.4103/0975-9476.128857.
2
Variation in skin hydration on the basis of (body constitution): A cross-sectional observational study.基于(身体体质)的皮肤水合作用差异:一项横断面观察性研究。
Ayu. 2018 Jul-Sep;39(3):127-131. doi: 10.4103/ayu.AYU_171_16.
3
Functional signature analysis of extreme Prakriti endophenotypes in gut microbiome of western Indian rural population.印度西部农村人口肠道微生物群中极端体质内表型的功能特征分析
Bioinformation. 2019 Jul 31;15(7):490-505. doi: 10.6026/97320630015490. eCollection 2019.
4
Traditional Medicine to Modern Pharmacogenomics: Ayurveda Prakriti Type and CYP2C19 Gene Polymorphism Associated with the Metabolic Variability.传统医学到现代药物基因组学:阿育吠陀体质类型和 CYP2C19 基因多态性与代谢变异性相关。
Evid Based Complement Alternat Med. 2011;2011:249528. doi: 10.1093/ecam/nep206. Epub 2011 Jun 8.
5
Prakriti Analysis of COVID 19 Patients: An Observational Study.COVID-19 患者的体质分析:一项观察性研究。
Altern Ther Health Med. 2021 Jun;27(S1):12-17.
6
Estimation of prakriti (body constitution) in women of Eastern Maharashtra tribal belt of central India featuring early and premature menopause.印度中部马哈拉施特拉邦东部部落地区存在早期和过早绝经现象的女性的体质评估。
J Family Med Prim Care. 2024 May;13(5):1665-1669. doi: 10.4103/jfmpc.jfmpc_376_23. Epub 2024 May 24.
7
Classification of human population based on HLA gene polymorphism and the concept of Prakriti in Ayurveda.基于人类白细胞抗原(HLA)基因多态性的人群分类与阿育吠陀中的体质概念
J Altern Complement Med. 2005 Apr;11(2):349-53. doi: 10.1089/acm.2005.11.349.
8
Whole genome expression and biochemical correlates of extreme constitutional types defined in Ayurveda.阿育吠陀中定义的极端体质类型的全基因组表达及生化关联
J Transl Med. 2008 Sep 9;6:48. doi: 10.1186/1479-5876-6-48.
9
Clinical Prediction of Type 2 Diabetes Mellitus (T2DM) via Anthropometric and Biochemical Variations in .通过人体测量和生化指标变化对2型糖尿病(T2DM)进行临床预测
Diseases. 2022 Mar 3;10(1):15. doi: 10.3390/diseases10010015.
10
Genome-wide analysis correlates Ayurveda Prakriti.全基因组分析与阿育吠陀体质相关。
Sci Rep. 2015 Oct 29;5:15786. doi: 10.1038/srep15786.

引用本文的文献

1
Ayurgenomics-based frameworks in precision and integrative medicine: Translational opportunities.精准与整合医学中基于阿育吠陀基因组学的框架:转化机遇。
Camb Prism Precis Med. 2023 Jun 15;1:e29. doi: 10.1017/pcm.2023.15. eCollection 2023.
2
Integrating ayurvedic medicine into cancer research programs part 1: Ayurveda background and applications.将阿育吠陀医学纳入癌症研究项目 第1部分:阿育吠陀医学背景与应用
J Ayurveda Integr Med. 2023 Mar-Apr;14(2):100676. doi: 10.1016/j.jaim.2022.100676. Epub 2022 Dec 19.
3
An Ayurgenomics Approach: Prakriti-Based Drug Discovery and Development for Personalized Care.

本文引用的文献

1
Prakriti-based medicine: A step towards personalized medicine.基于体质的医学:迈向个性化医疗的一步。
Ayu. 2011 Apr;32(2):141-6. doi: 10.4103/0974-8520.92539.
2
A short-term intervention trial on HIV positive patients using a Sri Lankan classical rasayana drug - Ranahamsa Rasayanaya.一项针对艾滋病毒阳性患者使用斯里兰卡传统养生药物——Ranahamsa Rasayanaya的短期干预试验。
Ayu. 2010 Apr;31(2):197-204. doi: 10.4103/0974-8520.72393.
3
Establishment of reference CD4+ T cell values for adult Indian population.建立成年印度人群 CD4+ T 细胞参考值。
一种阿育吠陀基因组学方法:基于体质的个性化医疗药物发现与开发。
Front Pharmacol. 2022 Apr 1;13:866827. doi: 10.3389/fphar.2022.866827. eCollection 2022.
4
Exploring AyuGenomics approach for understanding COVID-19 predisposition and progression.探索阿育吠陀基因组学方法以了解新冠病毒易感性和病程进展。
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100463. doi: 10.1016/j.jaim.2021.06.003. Epub 2021 Jun 17.
5
An Ayurvedic personalized prophylactic protocol in COVID-19.一种针对新冠肺炎的阿育吠陀个性化预防方案。
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100351. doi: 10.1016/j.jaim.2020.08.004. Epub 2020 Sep 8.
6
Ayurgenomics and Modern Medicine.阿育吠陀基因组学与现代医学。
Medicina (Kaunas). 2020 Nov 30;56(12):661. doi: 10.3390/medicina56120661.
7
Comparative gut microbiome analysis of the and systems reveals functional level similarities in constitutionally similar classes.对[具体两个系统名称缺失]和[具体两个系统名称缺失]系统的肠道微生物组进行比较分析,揭示了在体质相似类别中的功能水平相似性。
3 Biotech. 2020 Sep;10(9):379. doi: 10.1007/s13205-020-02376-1. Epub 2020 Aug 7.
8
Functional signature analysis of extreme Prakriti endophenotypes in gut microbiome of western Indian rural population.印度西部农村人口肠道微生物群中极端体质内表型的功能特征分析
Bioinformation. 2019 Jul 31;15(7):490-505. doi: 10.6026/97320630015490. eCollection 2019.
9
Reliability of Ayurvedic Diagnosis for Knee Osteoarthritis Patients: A Nested Diagnostic Study Within a Randomized Controlled Trial.阿育吠陀诊断膝关节骨关节炎患者的可靠性:一项随机对照试验中的嵌套诊断研究。
J Altern Complement Med. 2019 Sep;25(9):910-919. doi: 10.1089/acm.2018.0273. Epub 2019 Jan 17.
10
Significance of arterial stiffness in Tridosha analysis: A pilot study.动脉僵硬度在三体液分析中的意义:一项初步研究。
J Ayurveda Integr Med. 2017 Oct-Dec;8(4):252-256. doi: 10.1016/j.jaim.2017.02.012. Epub 2017 Nov 2.
AIDS Res Ther. 2011 Oct 3;8:35. doi: 10.1186/1742-6405-8-35.
4
Traditional medicine and genomics.传统医学与基因组学。
J Ayurveda Integr Med. 2010 Jan;1(1):26-32. doi: 10.4103/0975-9476.59824.
5
Is pharmacogenomics a reality? Challenges and oppurtunities for India.药物基因组学成为现实了吗?印度面临的挑战与机遇。
Indian J Hum Genet. 2011 May;17 Suppl 1(Suppl 1):S1-3. doi: 10.4103/0971-6866.80350.
6
Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society.胰岛抗原反应性 T 细胞分析用外周血单个核细胞的分离和保存:糖尿病学会免疫分会 T 细胞工作组委员会立场声明。
Clin Exp Immunol. 2011 Jan;163(1):33-49. doi: 10.1111/j.1365-2249.2010.04272.x. Epub 2010 Oct 5.
7
Traditional Medicine to Modern Pharmacogenomics: Ayurveda Prakriti Type and CYP2C19 Gene Polymorphism Associated with the Metabolic Variability.传统医学到现代药物基因组学:阿育吠陀体质类型和 CYP2C19 基因多态性与代谢变异性相关。
Evid Based Complement Alternat Med. 2011;2011:249528. doi: 10.1093/ecam/nep206. Epub 2011 Jun 8.
8
Genomic and personalized medicine: foundations and applications.基因组学与个性化医学:基础与应用
Transl Res. 2009 Dec;154(6):277-87. doi: 10.1016/j.trsl.2009.09.005. Epub 2009 Oct 1.
9
Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward?受传统医学启发的药物发现方法:阿育吠陀医学能指明前进的方向吗?
Drug Discov Today. 2009 Aug;14(15-16):804-11. doi: 10.1016/j.drudis.2009.05.009. Epub 2009 May 27.
10
Specific detection of CD56 (NCAM) isoforms for the identification of aggressive malignant neoplasms with progressive development.用于识别具有进展性发展的侵袭性恶性肿瘤的CD56(神经细胞黏附分子)亚型的特异性检测
Am J Pathol. 2009 Apr;174(4):1160-71. doi: 10.2353/ajpath.2009.080647. Epub 2009 Feb 26.